12 August 2023 : Clinical Research
Transgastric Jejunostomy (PEG-J) for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel: An Approach for Parkinson's Disease Treatment
Yusuke Nomoto1ABCDEF*, Makoto Furihata1ABCDEF, Haruka Hagiwara1F, Hirotaka Ishino1B, Shintaro Yano1D, Hiroki Okawa1B, Yoichi Nakatsu1B, Kumiko Noda1B, Shinjiro Nishi1F, Shingo Ogiwara1AB, Tsuneo Kitamura1D, Taro Osada1AGDOI: 10.12659/MSM.941285
Med Sci Monit 2023; 29:e941285
Table 2 Procedure-related adverse events.
Procedure-related AEs | Events | Rate (%) | Occurrence period | Inevitability |
---|---|---|---|---|
Pneumonia | 2 | 4.55 | E/L | Ine/Inc |
Peritonitis | 1 | 2.27 | L | Ine |
Gastric ulcer | 1 | 2.27 | L | Ine |
Hemorrhage | 1 | 2.27 | E | Ine |
Skin trouble | 1 | 2.27 | L | Ine |
Organ injury | 0 | 0.00 | NA | NA |
Pneumoperitoneum | 0 | 0.00 | NA | NA |
Buried bumper syndrome | 0 | 0.00 | NA | NA |
Intestinal volvulus | 1 | 2.27 | L | Inc |
Ileum pulling syndrome | 1 ()# | 2.27 | L | Ine |
Total | 7 (8) | 15.9 (%) | ||
# – after the observation period; AE – adverse events; E – early AE; L – late AE; Ine – inevitable AE; Inc. – incidental AE; NA – not applicable. The rate was calculated as the number of events divided by gross procedures (n=44). |